The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Wonder if this might work for BRAF mutant CRC...

gfpiv
gfpiv CSN Member Posts: 59 Member
edited March 2014 in Colorectal Cancer #1
Given that KRAS/BRAF mutations generally preclude certain treatments (e.g. Cetuximab), I found this article about a very effective new drug specifically benefiting BRAF mutant melanoma patients interesting.

http://www.msnbc.msn.com/id/38854884/ns/health-cancer/

Of course CRC is a completely different animal from melanoma, even if the author does muse about potential efficacy for other types of cancer. And I'm sure we're a long way away from knowing if it might also work for CRC...much less getting FDA approval for such use. Though I wonder if one might be able to get a "compassionate care" exception for CRC use if one had essentially run out of other approved treatment options...
Like Care

Discussion Boards